Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

SIMPLE SUMMARY: As one of the most lethal human cancers, glioblastoma treatment is a real challenge because of several resistance mechanisms, including limited drug entry into the central nervous system through the blood–brain barrier and the vast heterogeneity of this family of tumors. In the devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Molina, Daniel, Mao, Xiaoman, Alfonso-Triguero, Paula, Lorenzo, Julia, Bruna, Jordi, Yuste, Victor J., Candiota, Ana Paula, Novio, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563739/
https://www.ncbi.nlm.nih.gov/pubmed/36230883
http://dx.doi.org/10.3390/cancers14194960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563739/
https://www.ncbi.nlm.nih.gov/pubmed/36230883
http://dx.doi.org/10.3390/cancers14194960

Ejemplares similares